help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on June 26, 2003, doi:10.1164/rccm.200212-1437OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200212-1437OCv1
168/5/581    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimizu, T.
Right arrow Articles by Majima, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimizu, T.
Right arrow Articles by Majima, Y.
American Journal of Respiratory and Critical Care Medicine Vol 168. pp. 581-587, (2003)
© 2003 American Thoracic Society


Original Article

In Vivo and In Vitro Effects of Macrolide Antibiotics on Mucus Secretion in Airway Epithelial Cells

Takeshi Shimizu, Shino Shimizu, Reiko Hattori, Esteban C. Gabazza and Yuichi Majima

Department of Otorhinolaryngology and Third Department of Internal Medicine, Mie University School of Medicine, Edobashi, Tsu, Mie, Japan

Correspondence and requests for reprints should be addressed to Takeshi Shimizu, M.D., Department of Otorhinolaryngology, Mie University School of Medicine, 2-174 Edobashi, Tsu, Mie 514, Japan. E-mail: tshimizu{at}clin.medic.mie-u.ac.jp

To examine the in vivo effects of macrolide antibiotics on mucus hypersecretion, we induced hypertrophic and metaplastic changes of goblet cells in rat nasal epithelium by intranasal instillation of ovalbumin (OVA) in OVA-sensitized rats and by intranasal LPS instillation. Oral administration of clarithromycin (CAM) (5–10 mg/kg) significantly inhibited OVA- and LPS-induced mucus production and neutrophil infiltration, whereas josamycin and ampicillin showed no effect. In vitro effects of macrolide antibiotics on airway epithelial cells were examined using NCI-H292 cells and human nasal epithelial cells cultured in air–liquid interface. Mucus secretion was evaluated by ELISA using anti-mucin monoclonal antibodies (anti-MUC5AC and HCS18). CAM and erythromycin significantly inhibited spontaneous and tumor necrosis factor–{alpha} (20 ng/ml)–induced mucus secretion from NCI-H292 cells at 10-6 to 10-7 M and from human nasal epithelial cells at 10-4 to 10-5 M. MUC5AC messenger RNA expression was also significantly inhibited. These results indicate that the 14-member macrolide antibiotics, CAM and erythromycin, exert direct inhibitory effects on mucus secretion from airway epithelial cells and that they may be useful for the treatment of mucus hypersecretion caused by allergic inflammation and LPS stimulation.

Key Words: ovalbumin • lipopolysaccharide • goblet cell • nose




This article has been cited by other articles:


Home page
Eur Respir JHome page
R. Stamatiou, E. Paraskeva, K. Boukas, K. I. Gourgoulianis, P-A. Molyvdas, and A. A. Hatziefthimiou
Azithromycin has an antiproliferative and autophagic effect on airway smooth muscle cells
Eur. Respir. J., September 1, 2009; 34(3): 721 - 730.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. Beigelman, S. Gunsten, C. L. Mikols, I. Vidavsky, C. L. Cannon, S. L. Brody, and M. J. Walter
Azithromycin Attenuates Airway Inflammation in a Noninfectious Mouse Model of Allergic Asthma
Chest, August 1, 2009; 136(2): 498 - 506.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
H. Ishimoto, H. Mukae, N. Sakamoto, M. Amenomori, T. Kitazaki, Y. Imamura, H. Fujita, H. Ishii, S. Nakayama, K. Yanagihara, et al.
Different effects of telithromycin on MUC5AC production induced by human neutrophil peptide-1 or lipopolysaccharide in NCI-H292 cells compared with azithromycin and clarithromycin
J. Antimicrob. Chemother., January 1, 2009; 63(1): 109 - 114.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
I. Cervantes-Sandoval, J. d. J. Serrano-Luna, E. Garcia-Latorre, V. Tsutsumi, and M. Shibayama
Mucins in the host defence against Naegleria fowleri and mucinolytic activity as a possible means of evasion
Microbiology, December 1, 2008; 154(12): 3895 - 3904.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
V. Poletti, G. Casoni, M. Chilosi, and M. Zompatori
Diffuse panbronchiolitis
Eur. Respir. J., October 1, 2006; 28(4): 862 - 871.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
K. K. Brown
Chronic Cough Due to Nonbronchiectatic Suppurative Airway Disease (Bronchiolitis): ACCP Evidence-Based Clinical Practice Guidelines
Chest, January 1, 2006; 129(1_suppl): 132S - 137S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. F. Harris, M. J. Fischer, J. R. Hotchkiss, B. P. Monia, S. H. Randell, J. R. Harkema, and Y. Tesfaigzi
Bcl-2 Sustains Increased Mucous and Epithelial Cell Numbers in Metaplastic Airway Epithelium
Am. J. Respir. Crit. Care Med., April 1, 2005; 171(7): 764 - 772.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
B. K. Rubin and M. O. Henke
Immunomodulatory Activity and Effectiveness of Macrolides in Chronic Airway Disease
Chest, February 1, 2004; 125 (2009): 70S - 78S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Asthma, Airway Biology, and Nasal Disorders in AJRCCM 2003
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 265 - 276.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2003 American Thoracic Society
  Mastering Teaching Skills in Pulm & Crit Care Med